Axcelis Technologies, Inc. designs, manufactures and services the ion implantation and other processing equipment used in the manufacture of semiconductor chips in the United States, Europe and Asia. The company is headquartered in Beverly, Massachusetts.
| Revenue (TTM) | $866.07M |
| Gross Profit (TTM) | $372.51M |
| EBITDA | $99.39M |
| Operating Margin | 9.43% |
| Return on Equity | 8.89% |
| Return on Assets | 4.12% |
| Revenue/Share (TTM) | $28.00 |
| Book Value | $33.68 |
| Price-to-Book | 2.61 |
| Price-to-Sales (TTM) | 3.54 |
| EV/Revenue | 2.793 |
| EV/EBITDA | 18.75 |
| Quarterly Earnings Growth (YoY) | -23.50% |
| Quarterly Revenue Growth (YoY) | 10.60% |
| Shares Outstanding | $30.88M |
| Float | $30.69M |
| % Insiders | 0.68% |
| % Institutions | 102.02% |
Volatility is currently expanding
Axcelis Technologies NASDAQ: ACLS reported third-quarter 2026 revenue of $238 million and earnings per diluted share of $1.26, exceeding its expectations as demand improved across several semiconductor equipment markets.
Axcelis Technologies (ACLS) came out with quarterly earnings of $1.26 per share, beating the Zacks Consensus Estimate of $1.11 per share. This compares to earnings of $1.21 per share a year ago.
Q3 2026 Highlights: Revenue of $237.8 million GAAP Gross Margin of 41.0%, and Non-GAAP Gross Margin of 41.2% GAAP Operating Margin of 11.5% and Non-GAAP Operating Margin of 16.6% GAAP Diluted Earnings Per Share of $1.21, and Non-GAAP Diluted Earnings Per Share of $1.26 BEVERLY, Mass., Nov. 5, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS) today announced financial results for the third quarter ended September 30, 2026.
Merger now expected to close by the end of the first quarter of 2027 BEVERLY, Mass., and PLAINVIEW, N.Y.
BEVERLY, Mass., Oct. 27, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, today announced the appointment of Jeroen Delsman as Executive Vice President and Chief Financial Officer effective November 12, 2026.
BEVERLY, Mass., Oct. 21, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, will release financial results for the third quarter of 2026 before the opening of the market on Thursday, November 5, 2026.
$35 Million Investment Will Expand Axcelis' Manufacturing Capacity and Enable the Company to Better Serve Customers BEVERLY, Mass., Oct. 20, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, today announced that it will officially break ground on its new ion implantation equipment manufacturing facility in Pyeongtaek, Gyeonggi Province, Korea.
In the closing of the recent trading day, Axcelis Technologies (ACLS) stood at $142.31, denoting a -3.69% move from the preceding trading day.
BEVERLY, Mass., Sept. 21, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, will be participating in the 23rd International Conference on Silicon Carbide and Related Materials (ICSCRM 2026) taking place September 28 - October 2, 2026, at the Pacifico Yokohama North in Japan.
Axcelis Technologies (ACLS) concluded the recent trading session at $103.75, signifying a -1.23% move from its prior day's close.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on ACLS and any ticker you trade — then tracks every position and per-strategy win rate.
